Share price of Fate Therapeutics Inc (NASDAQ:FATE) gained 10.3% after the company released fourth quarter earnings but lost 4.0% in the next trading session. Overall, shares gained 6.15% following the fourth quarter results. Fate Therapeutics Inc (NASDAQ:FATE) shares after opening at $11.02 moved to $11.07 on last trade day and at the end of the day closed at $9.74. Company price to sales ratio in past twelve months was calculated as 124.43 and price to cash ratio as 10.42. Fate Therapeutics Inc (NASDAQ:FATE) showed a negative weekly performance of -14.19%.
Clean Diesel Technologies, Inc. (NASDAQ:CDTI)’s stock dropped 9.24% to $3.83. The company on Mar. 31 announced its financial results for the fourth quarter and fiscal year ended Dec. 31, 2013. Total revenue for the fourth quarter of 2013 was $15.2 million, an increase of $2.8 million, or 22.6%, from $12.4 million for the prior year quarter. Clean Diesel Technologies, Inc. (NASDAQ:CDTI) shares fell -9.95% in last trading session and ended the day on $3.80. CDTI return on equity ratio is recorded as -83.10% and its return on assets is -22.80%. Clean Diesel Technologies, Inc. (NASDAQ:CDTI) yearly performance is 77.57%.
Sorl Auto Parts (NASDAQ:SORL) was down 3.5% on Monday following a weaker than expected earnings announcement, American Banking News reports. The company traded as low as $3.72 and last traded at $4.14, with a volume of 251,498 shares changing hands. The stock had previously closed at $4.29. Sorl Auto Parts, Inc. (NASDAQ:SORL) shares moved down -13.05% in last trading session and was closed at $3.73 while trading in range of $3.69 – $4.30. Sorl Auto Parts, Inc. (NASDAQ:SORL) year to date (YTD) performance is -6.28%.
Momenta Pharmaceuticals Inc. (Nasdaq:MNTA) announced that the U.S. Supreme Court has granted the Company’s COPAXONE certiorari petition and will hear its appeal of a decision from the United States Court of Appeals for the Federal Circuit that invalidated the claim of U.S. Patent 5,800,808. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) weekly performance is -18.65%. On last trading day company shares ended up $11.65. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) distance from 50-day simple moving average (SMA50) is -29.85%. Analysts mean target price for the company is $19.75.
Leave a Reply